Skip to content

Study · Not a test of the peptide alone · 2017

1 result

[Local immune and oxidative status in exacerbated chronic apical periodontitis].

Konoplya AI, Goldobin DD, Loktionov AL

Stomatologiia1 Jan 2017Cited by 1 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Gepon was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Gepon.

  1. 01HumanNot a test of Gepon aloneNon-randomized trialEfficacy outcome

    In patients with exacerbated chronic apical periodontitis, Gepon with Essentiale forte H and Kaskatol was among the most effective combinations for correcting imbalance.

    In plain wordsIn patients with worsened chronic apical periodontitis, the Gepon combination was among the most effective combinations for correcting immune and oxidative imbalance.

    Peptide
    Gepon
    Outcome
    Not applicableCorrection of local immune and oxidative imbalance
    Study

    n: not reported in source

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Combination of Gepon or Vobenzim with Essentiale forte H and Kaskatol proved to be the most effective for correction of this imbalance.
    2 context sentences
    Summary · context
    The aim of the study was to define local immune and oxidative changes in patients with exacerbated chronic apical periodontitis.
    Summary · context
    These changes were assessed in saliva of 67 patients with the mean age of 31±2.5 before and after treatment.

    In this study, Gepon was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Gepon.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    27 Oct 2026, 18:20 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:32 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.